دورية أكاديمية
668P Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer
| العنوان: | 668P Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer |
|---|---|
| المؤلفون: | Drilon, A., Shen, L., van Tilburg, C., Doz, F., Tan, D.S.W., Lin, J.J., Kummar, S., Lassen, U.N., McDermott, R.S., Dierselhuis, M.P., Albert, C.M., Nagasubramanian, R., Watt, T., Patil, T., Burcoveanu, D-I., Norenberg, R., Brega, N., Laetsch, T.W., Xu, R-H., Hong, D.S. |
| المصدر: | Annals of Oncology ; volume 34, page S470 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2023.09.1854 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2023.09.1854Test https://api.elsevier.com/content/article/PII:S0923753423026911?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753423026911?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.2E5A46E |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2023.09.1854 |
|---|